Patent ID: 9555063
Date: 2017-01-31
CPC Classifications: A61K

Claim:
1. A therapeutic composition for enhancing protein synthesis in a damaged or diseased tissue in a human, the composition comprising: a) at least one extracellular matrix compound selected from glycosaminoglycan, proteoglycan aggregate complex of hyaluronic acid, extracellular matrix protein and chondroitin in an amount effective as an anti-neo-inflammatory and anti-neo-angiogenetic agent in the damaged or diseased tissue; b) about one to three grams of at least one polar surface active lipid selected from the group consisting of phosphatidic acid, phosphatidylethanolamine, lecithin, phosphatidylserine, phosphatidylinositol, 2-lysolecithin, plasmalogen, choline plasmalogen, phostidylglycerol, diphosphatidylglycerol, sphingomyelin, and any combination of 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 of said polar active surface lipids; c) a plurality of enantiomerically pure L-amino acids and glycine of about 9 to 25 grams in a molar ratio that is representative of the molar ratio of amino acids in a normal human tissue corresponding to the damaged or diseased tissue; d) a component selected from the group consisting of Polyoxyethlene Sorbitan Monooleate, Sorbitan monooleate, grape seed extract, grape extract, and combinations thereof; and e) vitamins, minerals or trace elements selected from the group consisting of Vitamin B12, Vitamin E, selenium, zinc, and combinations thereof.